新鳳鳴(603225.SH):全資子公司中石科技向其全資子公司增資
格隆匯8月28日丨新鳳鳴(603225.SH)公佈,根據公司戰略發展目標和需要,公司全資子公司新鳳鳴集團湖州中石科技有限公司(以下簡稱“中石科技”)以自有資金向其全資子公司浙江獨山能源有限公司(以下簡稱“獨山能源”)新增100,000萬元人民幣註冊資本,新增註冊資本後獨山能源註冊資本變更為500,000萬元,並仍為中石科技全資子公司,即公司全資孫公司;以自有資金向其全資子公司湖州市中磊化纖有限公司(以下簡稱“中磊化纖”)新增50,000萬元人民幣註冊資本,新增註冊資本後中磊化纖註冊資本變更為150,000萬元,並仍為中石科技全資子公司,即公司全資孫公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.